Literature DB >> 10180790

Effective management of stable angina.

M Petticrew1, M Sculpher, J Kelland, R Elliott, D Holdright, M Buxton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10180790      PMCID： PMC2483589          DOI： 10.1136/qshc.7.2.109

Source DB:  PubMed          Journal:  Qual Health Care        ISSN： 0963-8172


× No keyword cloud information.
  44 in total

1.  Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.

Authors:  E J Topol; J J Ferguson; H F Weisman; J E Tcheng; S G Ellis; N S Kleiman; R J Ivanhoe; A L Wang; D P Miller; K M Anderson; R M Califf
Journal:  JAMA       Date:  1997-08-13       Impact factor: 56.272

2.  Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris.

Authors:  H W Vliegen; E E van der Wall; M G Niemeyer; N J Holwerda; P J Bernink; P de Weerd; A H Bosma; L R van der Wieken; A J Timmermans; G P Molhoek
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

3.  Controlled clinical trial of bepridil, propranolol and placebo in the treatment of exercise induced angina pectoris. B.I.S. Research Group.

Authors:  J M Destors; J P Boissel; A M Philippon; J Schbath
Journal:  Fundam Clin Pharmacol       Date:  1989       Impact factor: 2.748

4.  The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.

Authors:  J Boberg; F F Larsen; S K Pehrsson
Journal:  Clin Cardiol       Date:  1992-08       Impact factor: 2.882

5.  In-hospital costs associated with new percutaneous coronary devices.

Authors:  R J Dick; J J Popma; D W Muller; K A Burek; E J Topol
Journal:  Am J Cardiol       Date:  1991-10-01       Impact factor: 2.778

6.  A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina.

Authors:  W Nahrendorf; A Rading; G Steinig; R van der Does; A Schlote
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

7.  A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.

Authors:  A F Parisi; E D Folland; P Hartigan
Journal:  N Engl J Med       Date:  1992-01-02       Impact factor: 91.245

8.  Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination.

Authors:  D T Kawanishi; C L Reid; E C Morrison; S H Rahimtoola
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

9.  Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. The Investigators of Study 152.

Authors:  S Singh
Journal:  Clin Cardiol       Date:  1993-01       Impact factor: 2.882

10.  Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.

Authors:  S Juul-Möller; N Edvardsson; B Jahnmatz; A Rosén; S Sørensen; R Omblus
Journal:  Lancet       Date:  1992-12-12       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.